Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches
about
Intracellular and circulating neuronal antinuclear antibodies in human epilepsyPathophysiological implications of neurovascular P450 in brain disordersMicroRNAs in the pathophysiology and treatment of status epilepticusInflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex.Blood-brain barrier, bulk flow, and interstitial clearance in epilepsyOntogeny of ABC and SLC transporters in the microvessels of developing rat brainPharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disordersEndothelial β-Catenin Signaling Is Required for Maintaining Adult Blood-Brain Barrier Integrity and Central Nervous System Homeostasis.Late-onset epilepsy and occult cerebrovascular diseaseAdvances in Autoimmune Epilepsy Associated with Antibodies, Their Potential Pathogenic Molecular Mechanisms, and Current Recommended ImmunotherapiesIs peripheral immunity regulated by blood-brain barrier permeability changes?Nonconvulsive seizures in subarachnoid hemorrhage link inflammation and outcome.P-gp Protein Expression and Transport Activity in Rodent Seizure Models and Human EpilepsyWONOEP appraisal: Molecular and cellular biomarkers for epilepsy.A role for human brain pericytes in neuroinflammation.Redistribution of PDGFRβ cells and NG2DsRed pericytes at the cerebrovasculature after status epilepticusIn vitro cerebrovascular modeling in the 21st century: current and prospective technologies.Different permeability of potassium salts across the blood-brain barrier follows the Hofmeister seriesPerforin competent CD8 T cells are sufficient to cause immune-mediated blood-brain barrier disruption.WONOEP appraisal: Development of epilepsy biomarkers-What we can learn from our patients?The possible role of GABAA receptors and gephyrin in epileptogenesis.Modulatory effects of perforin gene dosage on pathogen-associated blood-brain barrier (BBB) disruption.Issues in Clinical Epileptology: A View from the Bench. A Festschrift in Honor of Philip A. Schwartzkroin, PhD.Cerebrovascular remodeling and epilepsyPeroxisome proliferator-activated receptors and Alzheimer's disease: hitting the blood-brain barrier.Inflammatory pathways of seizure disorders.Microglia-Mediated Inflammation and Neurodegenerative Disease.Nodding syndrome, western Uganda, 1994.Inflammatory aspects of epileptogenesis: contribution of molecular inflammatory mechanisms.WONOEP appraisal: Imaging biomarkers in epilepsy.The Progress of Epilepsy after Stroke.Blood-brain barrier and foetal-onset hydrocephalus, with a view on potential novel treatments beyond managing CSF flow.Role of the Golgi Apparatus in the Blood-Brain Barrier: Golgi Protection May Be a Targeted Therapy for Neurological Diseases.Exendin-4 Reverses Biochemical and Functional Alterations in the Blood-Brain and Blood-CSF Barriers in Diabetic Rats.Blood-brain barrier leakage after status epilepticus in rapamycin-treated rats I: Magnetic resonance imaging.Blood-brain barrier leakage after status epilepticus in rapamycin-treated rats II: Potential mechanisms.Does angiogenesis play a role in the establishment of mesial temporal lobe epilepsy?Glycaemic control boosts glucosylated nanocarrier crossing the BBB into the brain.Selective Limbic Blood-Brain Barrier Breakdown in a Feline Model of Limbic Encephalitis with LGI1 Antibodies.Chemokine CCL2-CCR2 Signaling Induces Neuronal Cell Death via STAT3 Activation and IL-1β Production after Status Epilepticus.
P2860
Q22252354-124C8CC9-E529-4C93-B361-43AE6031B70FQ26745632-BBCD7AA8-A906-4D77-8254-DD5E43AF40FCQ27004814-DEA8433A-9D1D-4C8A-83D8-29951BF81DE0Q27308042-B2C94691-D47E-4487-934C-64E02D0BD4EFQ28086846-B82709E0-4372-49E3-9B5C-4BA879D2AF20Q28566257-313B8649-0C0A-470F-BAE9-2E3A5CC14128Q29048615-75ED4ACC-F893-41C1-B616-0EF3A73131D7Q30734754-0349350A-5C20-4252-B3DE-372AF8A29AE9Q30755317-D41BDCF3-F0C2-4E24-B032-3CDC1915BAB2Q33600142-C56A0C8B-5284-4374-BFD1-27568557F647Q33838466-35A7FD82-5692-4061-9503-DD21AFB44F86Q33856333-BCC1FE50-FA1A-49E3-834F-A8B6C57AD64BQ33875127-4870D9B4-0D3C-4F4F-BA64-2B7A7E20E217Q33915194-7DFB8F34-D76A-4FEF-957A-046CDA131B3FQ33926836-2B3C07E4-3153-41B5-83C7-D0375EDA8853Q34266638-41B78447-C724-4716-B7F2-BB5995630F10Q34476565-132CEE87-60DD-4359-BE5F-E99A3256C8D8Q35036513-BA84F43C-D581-4A0A-938E-F32B014E003AQ35357969-6D21F9BA-9C44-4711-A3B9-8860535D85FCQ36339575-ED35426C-E0B8-4EC7-9BCC-8ED747CEE9F0Q37030003-79749467-531B-40EC-A1CD-F0C282B845D5Q37220962-D63D16F0-F78F-45DB-89C7-93D724509D10Q37372251-EF33A25F-D201-4940-A8C6-46E3654C75DDQ38052687-DF5D6EFE-4712-410C-8273-B252E9AA1BC9Q38089668-06F885D1-CC8C-410F-8F20-0E63FAF4C69BQ38172740-32B75AD9-2390-48B6-B267-C69E842D5597Q38667336-9EB3426C-6028-48BE-9CBB-27D008496E2EQ38859273-8ABC2B15-0026-449C-ABD5-AF953D0FCEBDQ38969134-64426F41-A7E3-4E59-9D6C-D59B2F29AB18Q39018707-68CDBD33-A28E-4FDD-972C-EBBEFDA287BDQ39367273-9BB34EAE-0FD6-4B6C-BED7-3A8F4B51C799Q39431098-3781DCE3-0915-465B-9204-542193FC558AQ39449749-C05B2AC1-C6FE-4116-948A-2D23F66BB461Q39959089-E8C1DE12-435C-488F-A87F-FFD16504CFF5Q40183729-6B7B2C0B-6D76-4E63-A1E2-E08450D120E1Q40183907-8F09AC2B-4ABB-4B96-ADBF-7A8503ED77D9Q41895525-EA0E34F0-D1A6-45D2-86DD-727BD4E53854Q42379631-DF117516-CBCD-473A-A028-3B8FF4A7B144Q47108705-DB811E21-8490-4082-8266-BF8891F65858Q48112617-ED9015BD-76D2-4AD2-81E0-DFE1F68C4376
P2860
Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Blood-brain barrier dysfunctio ...... ole and therapeutic approaches
@ast
Blood-brain barrier dysfunctio ...... ole and therapeutic approaches
@en
type
label
Blood-brain barrier dysfunctio ...... ole and therapeutic approaches
@ast
Blood-brain barrier dysfunctio ...... ole and therapeutic approaches
@en
prefLabel
Blood-brain barrier dysfunctio ...... ole and therapeutic approaches
@ast
Blood-brain barrier dysfunctio ...... ole and therapeutic approaches
@en
P2860
P50
P1433
P1476
Blood-brain barrier dysfunctio ...... ole and therapeutic approaches
@en
P2860
P304
P356
10.1111/J.1528-1167.2012.03637.X
P577
2012-08-20T00:00:00Z